Concepedia

Richard Marsden

RM

Statistics

Publications

3

Citations

755

H-Index

3

Active since

2014

Affiliations

University Hospital Southampton NHS Foundation Trust(Current)

Synairgen (United Kingdom)

University of Southampton

Nottingham City Hospital

University of Nottingham

Richard Marsden is an author at University Hospital Southampton NHS Foundation Trust specializing in respiratory disease, pharmacy, and antiviral therapy.

Publications per year

2014–2020

3

Publications

3

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Phillip Monk, Richard Marsden, Victoria Tear et al. · The Lancet Respiratory Medicine · 2020 · 455 citations · Full text

, , +10

The Effect of Inhaled IFN-β on Worsening of Asthma Symptoms Caused by Viral Infections. A Randomized Trial

Ratko Djukanović, Tim Harrison, Sebastian L. Johnston et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 269 citations · Full text

, , +17

INEXAS: A Phase 2 Randomized Trial of On‐demand Inhaled Interferon Beta‐1a in Severe Asthmatics

Christopher McCrae, Marita Olsson, Per Gustafson et al. · Clinical & Experimental Allergy · 2020 · 31 citations · Full text

, , +17

1–3 of 3